JP2012505154A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012505154A5 JP2012505154A5 JP2011517819A JP2011517819A JP2012505154A5 JP 2012505154 A5 JP2012505154 A5 JP 2012505154A5 JP 2011517819 A JP2011517819 A JP 2011517819A JP 2011517819 A JP2011517819 A JP 2011517819A JP 2012505154 A5 JP2012505154 A5 JP 2012505154A5
- Authority
- JP
- Japan
- Prior art keywords
- microglobulin
- alpha
- pharmaceutical composition
- composition according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13533808P | 2008-07-18 | 2008-07-18 | |
| DKPA200801024 | 2008-07-18 | ||
| DKPA200801024 | 2008-07-18 | ||
| US61/135,338 | 2008-07-18 | ||
| US18938108P | 2008-08-18 | 2008-08-18 | |
| US61/189,381 | 2008-08-18 | ||
| DKPA200801116 | 2008-08-18 | ||
| DKPA200801116 | 2008-08-18 | ||
| US19750608P | 2008-10-27 | 2008-10-27 | |
| US61/197,506 | 2008-10-27 | ||
| DKPA200801478 | 2008-10-27 | ||
| DKPA200801478 | 2008-10-27 | ||
| PCT/EP2009/005217 WO2010006809A2 (en) | 2008-07-18 | 2009-07-17 | Medical use of the radical scavenger and antioxidant alpha-1-microglobulin |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014236500A Division JP6406987B2 (ja) | 2008-07-18 | 2014-11-21 | ラジカルスカベンジャー及び抗酸化剤アルファ−１−ミクログロブリンの医薬的使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012505154A JP2012505154A (ja) | 2012-03-01 |
| JP2012505154A5 true JP2012505154A5 (enExample) | 2012-09-06 |
| JP5694928B2 JP5694928B2 (ja) | 2015-04-01 |
Family
ID=41550762
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011517819A Expired - Fee Related JP5694928B2 (ja) | 2008-07-18 | 2009-07-17 | ラジカルスカベンジャー及び抗酸化剤アルファ−１−ミクログロブリンの医薬的使用 |
| JP2014236500A Expired - Fee Related JP6406987B2 (ja) | 2008-07-18 | 2014-11-21 | ラジカルスカベンジャー及び抗酸化剤アルファ−１−ミクログロブリンの医薬的使用 |
| JP2015241096A Expired - Fee Related JP6175478B2 (ja) | 2008-07-18 | 2015-12-10 | ラジカルスカベンジャー及び抗酸化剤アルファ−１−ミクログロブリンの医薬的使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014236500A Expired - Fee Related JP6406987B2 (ja) | 2008-07-18 | 2014-11-21 | ラジカルスカベンジャー及び抗酸化剤アルファ−１−ミクログロブリンの医薬的使用 |
| JP2015241096A Expired - Fee Related JP6175478B2 (ja) | 2008-07-18 | 2015-12-10 | ラジカルスカベンジャー及び抗酸化剤アルファ−１−ミクログロブリンの医薬的使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10350268B2 (enExample) |
| EP (2) | EP2313106B1 (enExample) |
| JP (3) | JP5694928B2 (enExample) |
| AU (1) | AU2009270435B2 (enExample) |
| CA (1) | CA2730531A1 (enExample) |
| DK (2) | DK2638915T3 (enExample) |
| ES (2) | ES2571956T3 (enExample) |
| HR (2) | HRP20160760T1 (enExample) |
| HU (2) | HUE027953T2 (enExample) |
| PL (2) | PL2313106T3 (enExample) |
| PT (1) | PT2638915T (enExample) |
| WO (1) | WO2010006809A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004289252C1 (en) | 2003-11-08 | 2013-06-20 | Prothera Biologics, Inc. | Preparation and composition of Inter-alpha inhibitor proteins from human plasma for therapeutic use |
| WO2008098734A1 (en) | 2007-02-12 | 2008-08-21 | Stefan Hansson | Diagnosis and treatment of preeclampsia |
| AU2009260822B2 (en) | 2008-05-28 | 2016-09-22 | Prothera Biologics, Inc. | Preparation and composition of Inter-alpha inhibitor proteins from blood |
| ES2599034T3 (es) * | 2012-09-05 | 2017-01-31 | A1M Pharma Ab | Alfa-1-microglobulina para su uso en el tratamiento de enfermedades relacionadas con mitocondrias |
| WO2014039987A2 (en) | 2012-09-09 | 2014-03-13 | Prothera Biologics, Inc. | Treatment of disease using inter-alpha inhibitor proteins |
| WO2015095553A1 (en) | 2013-12-20 | 2015-06-25 | Nephrogenesis, Llc | Methods and apparatus for kidney dialysis |
| BR112018068522A2 (pt) * | 2016-03-18 | 2019-01-22 | A1M Pharma Ab | novas proteínas derivadas de alfa-1-microglobulina e seu uso |
| EP3512539A4 (en) | 2016-09-13 | 2020-07-29 | Prothera Biologics, Inc. | METHODS FOR TREATING LUNG DISEASE USING INTER-ALPHA INHIBITOR PROTEINS |
| WO2018094023A2 (en) * | 2016-11-16 | 2018-05-24 | Anand Prasad | Cyclic dipeptides and wound healing |
| BR112019022358A2 (pt) | 2017-04-25 | 2020-05-19 | Prothera Biologics Inc | métodos para quantificar proteínas inibidoras inter-alfa |
| CN111511386A (zh) * | 2017-11-03 | 2020-08-07 | 卫士医疗国际公司 | α-1-微球蛋白用于保护骨髓细胞的用途 |
| JP6906807B2 (ja) * | 2018-08-31 | 2021-07-21 | 一般社団法人クラインシュタイン医工学パースペクティブ | 透析装置 |
| WO2024165674A1 (en) | 2023-02-08 | 2024-08-15 | Guard Therapeutics International AB | Alpha-1-microglobulin derived peptide fragments and uses thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5166133A (en) * | 1991-04-17 | 1992-11-24 | Cetus Corporation | Method for inhibing adhesion of white blood cells to endothelial cells |
| US6103691A (en) * | 1994-03-23 | 2000-08-15 | Tschesche; Harald | Utilisation of angiogenin and/or α1 -microglobulin and/or complement factor D in order to inhibit the secretion of proteins |
| US5910482A (en) | 1996-03-19 | 1999-06-08 | Board Of Regents, The University Of Texas System | Treatment or prevention of preeclampsia, eclampsia with calcitonin gene related peptide, CGRP analog, progestational agent, nitric oxide source, and cyclooxygenase inhibitor |
| JP2001348342A (ja) | 2001-04-12 | 2001-12-18 | Nippon Zoki Pharmaceut Co Ltd | 免疫調整・抗炎症剤 |
| DE10125883A1 (de) | 2001-05-28 | 2002-12-12 | Serumwerk Bernburg Ag | Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie |
| DE10237423A1 (de) | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
| US20070060512A1 (en) * | 2003-03-04 | 2007-03-15 | Homayoun Sadeghi | Dipeptidyl-peptidase protected protein |
| AR045074A1 (es) | 2003-07-23 | 2005-10-12 | Applied Research Systems | Uso de cd164 soluble en desordenes inflamatorios y autoinmunes |
| ITMI20032528A1 (it) | 2003-12-19 | 2005-06-20 | Francesco Santangelo | Uso di cistina o di cisteina per la prevenzione e il |
| US20060105419A1 (en) | 2004-08-16 | 2006-05-18 | Biosite, Inc. | Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions |
| JP2007001922A (ja) | 2005-06-23 | 2007-01-11 | Asahi Kasei Pharma Kk | 透析患者における腎疾患改善剤、又は機能性食品 |
| US20070292421A1 (en) | 2005-07-28 | 2007-12-20 | Feinberg Bruce B | Method for treating preeclampsia |
| US20080133141A1 (en) | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
| WO2008098734A1 (en) * | 2007-02-12 | 2008-08-21 | Stefan Hansson | Diagnosis and treatment of preeclampsia |
-
2009
- 2009-07-17 EP EP09777272.7A patent/EP2313106B1/en active Active
- 2009-07-17 DK DK13172049.2T patent/DK2638915T3/en active
- 2009-07-17 CA CA2730531A patent/CA2730531A1/en not_active Abandoned
- 2009-07-17 ES ES09777272T patent/ES2571956T3/es active Active
- 2009-07-17 PL PL09777272T patent/PL2313106T3/pl unknown
- 2009-07-17 US US13/054,188 patent/US10350268B2/en active Active
- 2009-07-17 PT PT131720492T patent/PT2638915T/pt unknown
- 2009-07-17 EP EP13172049.2A patent/EP2638915B1/en not_active Not-in-force
- 2009-07-17 HU HUE09777272A patent/HUE027953T2/en unknown
- 2009-07-17 HU HUE13172049A patent/HUE030274T2/en unknown
- 2009-07-17 WO PCT/EP2009/005217 patent/WO2010006809A2/en not_active Ceased
- 2009-07-17 HR HRP20160760TT patent/HRP20160760T1/hr unknown
- 2009-07-17 PL PL13172049T patent/PL2638915T3/pl unknown
- 2009-07-17 JP JP2011517819A patent/JP5694928B2/ja not_active Expired - Fee Related
- 2009-07-17 AU AU2009270435A patent/AU2009270435B2/en not_active Ceased
- 2009-07-17 ES ES13172049.2T patent/ES2614490T3/es active Active
- 2009-07-17 DK DK09777272.7T patent/DK2313106T3/en active
-
2014
- 2014-11-21 JP JP2014236500A patent/JP6406987B2/ja not_active Expired - Fee Related
-
2015
- 2015-12-10 JP JP2015241096A patent/JP6175478B2/ja not_active Expired - Fee Related
-
2016
- 2016-12-29 HR HRP20161808TT patent/HRP20161808T1/hr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012505154A5 (enExample) | ||
| HRP20161808T1 (hr) | Medicinska uporaba hvatača radikala i antioksidansa alfa-1-mikroglobulin | |
| BR112022008641A2 (pt) | Métodos de tratamento com modulador de miosina | |
| WO2007119177A3 (en) | Modified release formulations and methods of treating inflammatory bowel disease | |
| WO2007076522A3 (en) | Treatment of peripheral vascular disease using postpartum-derived cells | |
| JP2014519333A5 (enExample) | ||
| WO2005001080A3 (en) | Postpartum-derived cells for use in treatment of disease of the heart and circulatory system | |
| CL2011000571A1 (es) | Uso de una combinacion de: a) un compuesto de formula (1) o una sal farmaceuticamente aceptable del mismo, b) interferon alfa y c) ribavirina para preparar un medicamento util para el tratamiento de una infeccion viral de la hepatitis c (hcv) o para aliviar uno o mas sintomas de la misma. | |
| AR079706A1 (es) | Composiciones, metodos para el tratamiento de enfermedades oculares relacionadas con la angiogenesis y uso | |
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| ATE511847T1 (de) | Pharmazeutische zubereitung für die behandlung entzündlicher erkrankungen des urogenitaltraktes | |
| IN2014KN02752A (enExample) | ||
| JP2017532343A5 (enExample) | ||
| BR112014003071A2 (pt) | tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical | |
| JP2018520208A5 (enExample) | ||
| NZ599930A (en) | Pharmaceutical compositions for the stimulation of stem cells. | |
| EP4285991A3 (en) | Methods of treating fabry disease in patients having a mutation in the gla gene | |
| EA200700214A1 (ru) | Мемантин в качестве дополнительной терапии к атипичным антипсихотическим средствам у больных шизофренией | |
| JP2009500045A5 (enExample) | ||
| WO2010091051A3 (en) | Therapeutic use of specialized endothelial progenitor cells | |
| BRPI0720236A2 (pt) | Composto ou sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar uma infecção bacteriana em um animal de sangue quente tal como o ser humano, e, composição farmacêutica | |
| BR112013009043A2 (pt) | composto, uso de um composto, e, método para tratar uma doença | |
| JP2009507474A5 (enExample) | ||
| Ipatov et al. | Epidemiologic, medical and social aspects of disability due to asthma in Ukraine | |
| Wedemeyer et al. | 61 FACTORS INFLUENCING PROGRESSION OF LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS OF THE 3-YEAR T2S-918-HCV STUDY WITH HCVE1 THERAPEUTIC VACCINATION |